7,810.00
0.00
(0.00%)
May 22 - Close
KOSDAQ
data delayed by 20 mins -
Disclaimer
Currency in KRW
| Range | - |
| 52 week | 5,100.00 - 11,350.00 |
| Open | - |
| Vol / Avg. | 0.00/309,579.00 |
| Mkt cap | 136.79B |
| P/E | 38.72 |
| Div/yield | 50.00/1.02 |
| EPS | 201.70 |
| Shares | 17.51M |
| Beta | - |
| Inst. own | - |
Key stats and ratios
| Q4 (Dec '11) | 2012 | |
| Net profit margin | 1.78% | 2.48% |
| Operating margin | 3.26% | 5.65% |
| EBITD margin | - | 7.88% |
| Return on average assets | 5.34% | 2.67% |
| Return on average equity | 8.97% | 5.41% |
| Employees | 310 | - |
| Carbon Disclosure Rating | - | - |
Address
308, Masan-Ri, Hoengseong-Eup
HOENGSEONG, 225804
South Korea
+82-33-3425140 (Phone)
+82-33-3420576 (Fax)
HOENGSEONG, 225804
South Korea
+82-33-3425140 (Phone)
+82-33-3420576 (Fax)
Website links
External links
Advertisement
Description
DAE HWA PHARM CO.,LTD. is a Korea-based company engaged in the manufacture of pharmaceuticals. The Company�s products include remedies for circulatory system, respiratory system, musculoskeletal systems, central nervous system, digestive system, liver diseases, skin diseases and joint inflammation, as well as anti-inflammatory drugs, painkillers, fever reducers, vitamins, healthcare food, topical drugs and other prescription drugs and over-the-counter (OTC) drugs. The Company distributes its products within domestic market and to overseas markets. As of December 31, 2011, the Company had three affiliated companies.
Officers and directors
| Han Gu Lee | Chairman of the Board, Co-Chief Executive Officer | |
| Byeong Tae Noh | President, Co-Chief Executive Officer, Director | |
| Gwon Seok Han | Managing Director | |
| Byeong Yun Hwang | Managing Director | |
| Mun Sang Jung | Managing Director | |
| Yeong Wu Cho | Assistant Managing Director | |
| Hyo Won Kang | Internal Auditor | |
| Jae Hyeong Kim | Assistant Managing Director | |
| Eun Seok Kim | Director | |
| Gyeong Yeol Baek | Non-Executive Independent Director |